ResearcherUniversity of MinnesotaActive in the last 2 years
Julia Davydova
Matched on ORCID iD 0000-0001-5766-5722; OpenAlex author ID A5048788127; NIH RePORTER profile ID 8916123. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 3)
- Trials
- 0
- Grants
- 3
- Labs led
- 1
- Collaborators
- 11
2012: 2 papers · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper, 1 grant · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper, 1 grant · 2024: none · 2025: none · 2026: 1 grant
Papers 7
- Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. Co-author DOI 10.1111/cas.15903↗
- Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer. Last author DOI 10.18632/oncotarget.24710↗
- Oncolytic Virotherapy Increases the Detection of Microscopic Metastatic Disease at Time of Staging Laparoscopy for Pancreatic Adenocarcinoma. First author DOI 10.1016/j.ebiom.2016.05.019↗
- Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer. Last author DOI 10.1016/j.surg.2015.01.006↗
- Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer. Co-author DOI 10.1002/ijc.27983↗
- Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy. Last author DOI 10.1016/j.amjsurg.2012.02.016↗
- Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy. First author DOI 10.1016/j.surg.2012.02.017↗
Grants 3
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masato Yamamoto · 6 shared papers, 1 shared grant, 2012–2023 · strength 1.23
- Grant Combination therapy with IFN expressing oncolytic adenovirus for pancreatic cancer R01CA228760↗
- Paper Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. DOI 10.1111/cas.15903↗
- Paper Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hams… DOI 10.18632/oncotarget.24710↗
- Christopher James LaRocca · 3 shared papers, 2015–2018 · strength 0.27
- Paper Oncolytic Virotherapy Increases the Detection of Microscopic Metastatic Disease at Time of Staging Laparoscopy for Panc… DOI 10.1016/j.ebiom.2016.05.019↗
- Paper Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hams… DOI 10.18632/oncotarget.24710↗
- Paper Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic ca… DOI 10.1016/j.surg.2015.01.006↗
- Kazuho Inoko · 1 shared paper, 2023 · strength 0.19
- Shuhei Shinoda · 1 shared paper, 2023 · strength 0.19
- Mizuho Sato‐Dahlman · 1 shared paper, 2023 · strength 0.19
- Nikita Sharma · 1 shared paper, 2023 · strength 0.19
- Selwyn Maurice Vickers · 4 shared papers, 2012–2015 · strength 0.17
- Paper Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic ca… DOI 10.1016/j.surg.2015.01.006↗
- Paper Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer. DOI 10.1002/ijc.27983↗
- Paper Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy. DOI 10.1016/j.surg.2012.02.017↗
- Leonard Armstrong · 3 shared papers, 2012–2015 · strength 0.12
- Paper Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic ca… DOI 10.1016/j.surg.2015.01.006↗
- Paper Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy. DOI 10.1016/j.surg.2012.02.017↗
- Paper Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancr… DOI 10.1016/j.amjsurg.2012.02.016↗
- Amanda O. Salzwedel · 1 shared paper, 2018 · strength 0.10
- Satoshi Yamasaki · 1 shared paper, 2013 · strength 0.05
- Amanda Kathleen Arrington · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.